AGC Biologics Expands Operations in Bothell, Washington
The new complex is located adjacent to the existing AGC Biologics facility in Bothell, and spans more than 150,000 square feet. The new addition will hold the company's process development labs and corporate administrative offices, and will provide expansion space for additional manufacturing capacity.
According to company officials, the new facilities allow AGC Biologics to continue its expansion in the United States, and will include a new R&D center dedicated to novel manufacturing technologies for faster development of therapeutic proteins.
"The expansion of our Bothell site is another substantial milestone for AGC Biologics and a commitment to our operations in Washington State. We continue to demonstrate our dedication to sustained growth in order to support our customers' increasing demand for both mammalian and microbial development and manufacturing services," said Gustavo Mahler, President & CEO of AGC Biologics.
"These new state-of-the-art facilities will enable us to meaningfully advance and further integrate the development, manufacturing, and commercial functions within our dynamic global headquarters, as well as provide additional footprint for further manufacturing expansion,” he added.
RespirTek Consulting Laboratory Builds Headquarters & Research Hub in Jackson County, Mississippi
How are Uncertain Times Altering Company Location Strategies?
2020 Gold & Silver Shovel Awards Recognize State and Local Economic Development Efforts
Infrastructure Investment as an Economic Stimulus Tool
2019 Top States for Doing Business: Georgia Ranks #1 Sixth Year in a Row
34th Annual Corporate Survey & the 16th Annual Consultants Survey
Site Selection 2020: The Importance of “Regional Depth” with Global Reach